EU-Japan Biotech & Pharma Partnering Conference 2026

16 Sept – 5 Oct 2026 | Osaka, Japan

HomeAgenda
Register
Register
Register

ServiceUpdated on 4 September 2026

Cell Line Development

About

Based in Vienna, Austria, Nuvonis Technologies provides GMP-compliant avian and mammalian cell banks to accelerate product development for biotechnology partners. The company facilitates the fast and reliable scale-up of manufacturing solutions for both pharmaceuticals (viral vectors) and cultivated meat. This is backed by core expertise in process development, CMC, and regulatory support, ensuring a seamless transition from research to production.

Organisation

Nuvonis Technologies

Company (SME/startup) / 中小企業・スタートアップ

Vienna, Austria

Similar opportunities